The DOI matches its Crossref record.
INCREASED DOPAMINE CONCENTRATION IN LIMBIC AREAS OF BRAIN FROM PATIENTS DYING WITH SCHIZOPHRENIA
Abstract
Dopamine, noradrenaline, glutamate decarboxylase (GAD) and choline acetyl-transferase (CAT) were measured in post-mortem brain samples from more than 50 patients dying with a hospital diagnosis of schizophrenia and an equal number of controls. GAD was measured in 14 different brain regions, and was significantly lower in both control and schizophrenia patients who died following a protracted illness. If GAD values from patients who died suddenly were compared, no significant differences were observed between the control and schizophrenia groups. There was also no differences between the CAT values measured in 13 different brain regions in the two groups. Noradrenaline values were not different in the two groups in most limbic areas or in the caudate nucleus, but were elevated in the schizophrenic group in nucleus accumbens and in anterior perforated substance. These differences were not, however, statistically significant. On the other hand dopamine concentrations in nucleus accumbens and in anterior perforated substance were significantly elevated (by 34 and 95 per cent, respectively) in the schizophrenia group as compared with controls, although dopamine values were not different in caudate nucleus, putamen, septal nuclei or amygdala. The finding of elevated concentrations of dopamine in certain areas of the limbic forebrain in schizophrenia is discussed in relation to current hypotheses of the involvement of dopamine in this illness, and the difficulties of determining whether the observed changes are related to chronic treatment with antischizophrenic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Benes, F. M. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350036005 · Cited by 890
Dopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880
Imaging Dopamine Receptors in the Human Brain by Positron Tomography
Wagner, H. N., Burns, H. D., Dannals, R. F., Wong, D. F., Langstrom, B., Duelfer, T., Frost, J. J., Ravert, H. T., Links, J. M., Rosenbloom, S. B., et al. (1983) · Science · doi:10.1126/science.6604315 · Cited by 741
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674
The Glutamatergic Dysfunction Hypothesis for Schizophrenia
Coyle, J. T. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017192 · Cited by 568
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
Pycock, C. J., Kerwin, R. W., & Carter, C. J. (1980) · Nature · doi:10.1038/286074a0 · Cited by 549
Some Cytoarchitectural Abnormalities of the Entorhinal Cortex in Schizophrenia
Arnold, S. E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310043008 · Cited by 526
Emerging principles of altered neural circuitry in schizophrenia
Benes, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00041-7 · Cited by 513
Neuropathology of Schizophrenia
Stevens, J. R. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290100011003 · Cited by 475
Schizophrenia: Some Current Neurochemical Approaches
Rodnight, R. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb11809.x · Cited by 460
Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia
Reynolds, G. P. (1983) · Nature · doi:10.1038/305527a0 · Cited by 415
A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia
Woo, T.-U., Whitehead, R. E., Melchitzky, D. S., & Lewis, D. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5341 · Cited by 410
Increased Brain Dopamine and Dopamine Receptors in Schizophrenia
Mackay, A. V. P. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090001001 · Cited by 397
Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics
Benes, F., Vincent, S., Alsterberg, G., Bird, E., & SanGiovanni, J. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-00924.1992 · Cited by 367
Self-citationNeuroplasticity of Neocortical Circuits in Schizophrenia
Lewis, D. A., & González-Burgos, G. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301563 · Cited by 365
The regional distribution of somatostatin, substance P and neurotensin in human brain
Cooper, P. E., Fernstrom, M. H., Rorstad, O. P., Leeman, S. E., & Martin, J. B. (1981) · Brain Research · doi:10.1016/0006-8993(81)91302-0 · Cited by 328
The Case for Frontostriatal Dysfunction in Schizophrenia
Robbins, T. W. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.391 · Cited by 308
Alterations in Chandelier Neuron Axon Terminals in the Prefrontal Cortex of Schizophrenic Subjects
Pierri, J. N., Chaudry, A. S., Woo, T.-U. W., & Lewis, D. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1709 · Cited by 294
Benes, F. M., Vincent, S. L., Marie, A., & Khan, Y. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00328-4 · Cited by 274
Benes, F. M. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.1014 · Cited by 268
GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia
Lewis, D. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00042-9 · Cited by 257
Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia
Lewis, D. A., Pierri, J. N., Volk, D. W., Melchitzky, D. S., & Woo, T.-U. W. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00061-x · Cited by 256
Kessler, R. M., Woodward, N. D., Riccardi, P., Li, R., Ansari, M. S., Anderson, S., Dawant, B., Zald, D., & Meltzer, H. Y. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.029 · Cited by 136
Metadata
- Authors
- BIRD, E. D., SPOKES, E. G. S., & IVERSEN, L. L.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1979
- Volume
- 102
- Issue
- 2
- Pages
- 347-360
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2004397445
- Cited by
- 211
- References
- 0
- FWCI
- 13.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.